Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics
The blood-brain barrier (BBB), while being the gatekeeper of the central nervous system (CNS), is a bottleneck for the treatment of neurological diseases. Unfortunately, most of the biologicals do not reach their brain targets in sufficient quantities. The antibody targeting of receptor-mediated tra...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2023-06-01
|
| Schriftenreihe: | Pharmaceutics |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1999-4923/15/6/1748 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
